Achieving high coverage in Rwanda’s national human papillomavirus vaccination programme

Agnès Binagwaho, Claire Wagner, Maurice Gatera, +3

Bulletin of the World Health Organization

Rwanda 20 years on: investing in life

Agnès Binagwaho, Paul E. Farmer, Sabin Nsanzimana, +64

The Lancet

EconomicsDevelopment AidEconomic DevelopmentDevelopment EconomicsBusiness +5

Integration of comprehensive women’s health programmes into health systems: cervical cancer prevention, care and control in Rwanda

Agnès Binagwaho, Fidèle Ngabo, Claire Wagner, +4

Bulletin of the World Health Organization

Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda: a time-series analysis

Fidèle Ngabo, Jacqueline E. Tate, Maurice Gatera, +6

The Lancet Global Health

Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme

Fidèle Ngabo, Silvia Franceschi, Iacopo Baussano, +8

BMC Infectious Diseases

The Economic Burden Attributable to a Child’s Inpatient Admission for Diarrheal Disease in Rwanda

Fidèle Ngabo, Mercy Mvundura, Lauren Gazley, +10

PLoS ONE

Successive introduction of four new vaccines in Rwanda: High coverage and rapid scale up of Rwanda's expanded immunization program from 2009 to 2013

Maurice Gatera, Sunil Bhatt, Fidèle Ngabo, +8

Vaccine

VaccinologyVaccine SafetyVaccinationHigh CoverageVaccine Target +10

Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda

Jacqueline E. Tate, Fidèle Ngabo, Philippe Donnen, +5

Clinical Infectious Diseases

Urine testing to monitor the impact of HPV vaccination in Bhutan and Rwanda

Silvia Franceschi, M. Chantal Umulisa, Ugyen Tshomo, +11

International Journal of Cancer

Hpv PrevalenceVirus EpidemiologyVaccine HesitancyCovid-19Preventive Medicine +16

A cost comparison of introducing and delivering pneumococcal, rotavirus and human papillomavirus vaccines in Rwanda

Fidèle Ngabo, Ann Levin, Susan A. Wang, +6

Vaccine